Meloxicam Eg

Meloxicam, the active ingredient in Meloxicam Eg, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis and acute musculoskeletal conditions in adults.

GNH USA supplies Meloxicam Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

- Osteoarthritis: alleviates joint pain and swelling, improving function. - Rheumatoid arthritis: decreases systemic inflammation and joint damage. - Juvenile rheumatoid arthritis: provides pain relief and reduces disease activity in pediatric patients. - Acute pain: offers rapid analgesia for short‑term musculoskeletal discomfort.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic injury: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Renal function: assess baseline kidney status and avoid in severe impairment. - Cardiovascular risk: use the lowest effective dose in patients with heart disease. - Gastrointestinal history: avoid in individuals with active ulcers or a history of GI bleeding. - Concomitant medications: review for drugs that increase bleeding risk. - Elderly patients: start with reduced dose and monitor closely. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam can alter the effects of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: heightened lithium serum concentrations. - Methotrexate: potential for enhanced toxicity.

Moderate Interactions (Monitor Closely): - Diuretics and antihypertensives: possible reduction in antihypertensive efficacy. - Selective serotonin reuptake inhibitors (SSRIs): additive risk of gastrointestinal bleeding. - Other NSAIDs or COX‑2 inhibitors: increased risk of renal and gastrointestinal adverse effects.